Elevance Health Stock: Looking Beyond Near-Term Issues, I'm A Buyer
Elevance Health's dependence on government plans is considerable, but even with very conservative growth expectations, ELV ...
Elevance Shares Dive After Insurer Faces ‘Unprecedented’ Medicaid Challenge
The company’s earnings missed expectations, the latest sign of how medical expenses are squeezing insurers’ government ...
又一家医疗保险公司下调盈利预期 Elevance(ELV.US)绩后暴跌
智通财经APP获悉，10月17日（周四）美股盘前，由于医疗补助支付不足，保险公司Elevance(ELV.US)公布的第三季度业绩不及华尔街预期，并下调了今年的盈利预期。该股盘前跌11.04%，报442.10美元。财报显示，Elevance第三降低营 ...
RBC下调Elevance目标价，维持"跑赢大市"评级
RBC Capital Markets调整了Elevance Health Inc. (NYSE:ELV)的目标价，将其从之前的$585下调至$478，同时继续给予该股票"跑赢大市"评级。此次调整是在公司宣布下调2024年每股收益 (EPS)指引后做出的。此外，Elevance预计2025年EPS增长将达到中单位数，这一数字明显低于其之前超过12%的长期增长目标。
Elevance’s Results Spark Managed-Care Selloff. Outlook Sours for Health Insurers.
Shares of Elevance Health were trading sharply lower after a guidance cut prompted by snags in the Medicaid business ...
Elevance Health Latest Insurer Battered By Higher Medical Costs
Elevance Health is the latest health insurance company to report higher-than-expected medical costs as third quarter profits ...
Truist Securities下调Elevance股票目标价格，但维持买入评级
周五，Truist Securities调整了对Elevance Health Inc. (NYSE: ELV)股票的展望，将目标价格从之前的$620下调至$520，同时维持对该公司股票的买入评级。 这一调整是在Elevance公布第三季度业绩后做出的。该季度业绩显示医疗损失率(MLR)上升，且2024年指引和2025年初步展望低于预期。这主要是由于Medicaid费率和严重程度不匹配持续施压所致 ...
Elevance makes a late cut to its 2024 forecast after seeing trouble in Medicaid
Elevance Health surprised Wall Street with a rare, late-year guidance cut Thursday after a jump in Medicaid costs marred its ...
美股异动 | Q3调整后每股收益低于预期 Elevance Health(ELV.US)跌超18%
智通财经APP获悉，周四，Elevance Health ...
Elevance Health slashes profit forecast on persistently high medical costs
Elevance Health cut its annual profit expectation on Thursday due to increased medical costs in its government-backed plans, ...
Elevance Health Stock Plunges on Profit Hit From Fall in Medicaid Memberships
Key Takeaways Elevance Health shares plunged Thursday after the insurer reported lower-than-expected earnings and cut its ...
Q3调整后每股收益低于预期 Elevance Health跌超18%
周四，Elevance Health (ELV.US)开盘大幅低开超18%，创阶段新低，截至发稿，跌13.68%，报429美元。消息面上，财报显示，该公司报告第三季度截至9月30日的净利润为10.1亿美元，或每股4.36美元，较上年同期的13亿美元，或每股5.45美元有所下降。调整后的收益为8.37美元，低于分析师预期的9.66美元每股。本季度的营业收入比去年同期增加了18亿美元，达到138亿美元 ...